Latest Conference Articles

AI and Human Collaboration Essential for Bio/pharma Innovation

October 29th 2025

Eva-Maria Hempe, NVIDIA, says AI collaboration optimizes life science research via routine automation, freeing human experts for complex strategy, ethics, and exploring scarce data.

Best Practices for AI Adoption in Pharmaceutical Research

October 29th 2025

Eva-Maria Hempe, NVIDIA, says AI platforms must integrate R&D data, overcoming silos, with adoption demanding a centralized strategy and change management.

CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development

October 29th 2025

CPHI 2025 awards spotlight progress in pharmaceutical manufacturing, API development, automated processing, and sustainability driving future production.

Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One

October 29th 2025

CPHI Europe

As Thermo Fisher’s Jennifer Cannon explains in this first part of a two-part interview, the collaboration is intended to help improve the speed and success of drug development.

Sustainability and Stability in Excipients

October 29th 2025

Pharmaceutical Technology® spoke with Peter Freed, head of Global Pharma CTS, Roquette, about a variety of materials-related topics including protein stability, tablet coating, sustainability, and securing the supply chain.

Maggie Saykali on the Critical Medicines Act and the Mandate for Local Production

October 29th 2025

Maggie Saykali, Cefic, emphasizes the importance of competitiveness and innovation for European manufacturers to create added value and maintain environmental standards.

Why Sound Science Is Pharma's Best Defense Against Regulatory Shifts

October 29th 2025

Nigel Langley of gChem discusses the company’s DMSO, proactive pharma strategies, and more in part 1 of a 2-part interview related to his presentation at CPHI Europe 2025.

Day One at CPHI Frankfurt Sees Announcements from ACG and Bora Pharmaceuticals

October 28th 2025

ACG showcased the expansion of its European presence, and Bora Pharmaceuticals participates in a discussion about CDMO innovation.

Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma

October 28th 2025

Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.

How Organ-on-Chip Tech and AI Are Transforming Drug Development

October 28th 2025

React4Life’s Silvia Scaglione emphasizes how organ-on-chip tech and AI are reshaping drug testing, personalized treatment, and the future of bio/pharma innovation.